Concepedia

Andrew Hertler

AH

Statistics

Publications

9

Citations

351

H-Index

9

Active since

1987

Affiliations

Duke Medical Center(Current)

Duke University

Andrew Hertler is an author at Duke Medical Center specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

1987–2020

9

Publications

9

A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemia.

Andrew Hertler, David M. Schlossman, Michael J. Borowitz et al. · PubMed · 1988 · 67 citations

, , +14

An anti‐CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albumin‐monensin

Andrew Hertler, David M. Schlossman, Michael J. Borowitz et al. · International Journal of Cancer · 1989 · 64 citations

, , +11

Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae.

Arthur E. Frankel, David M. Schlossman, Philip Welsh et al. · Molecular and Cellular Biology · 1989 · 55 citations · Full text

, , +14

Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia

John C. Byrd, Andrew Hertler, R B Weiss et al. · Annals of Oncology · 1995 · 48 citations · Full text

, , +12

Humoral Immune Response to a Ricin A Chain Immunotoxin in Patients with Metastatic Melanoma

Andrew Hertler, L E Spitler, Arthur E. Frankel · Cancer Drug Delivery · 1987 · 42 citations

, , +17

1–5 of 9